Araim Pharmaeuticals

Araim Pharmaceuticals is a clinical-stage biotechnology company providing technologies to address injuries and chronic diseases. Its lead compound, ARA 290, is a novel 11-amino acid peptide that stimulates tissue protection, repair, and anti-inflammatory signaling pathways through selective IRR activation.Araim Pharmaceuticals is headquartered in Tarrytown, New York.